Medi Caps Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: MEDICAPQ BSE: 523144
₹25.60
▼ -0.88 (-3.32%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
40/100
Moderate
Valuation
100/100
Undervalued
Momentum
48/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹32 Cr
PE (TTM)
Data unavailable.
Price to Book
0.3
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-8 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-46.88%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
24.36%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-0.17%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-48.24%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-40.07%
as of March 31, 2026
Industry median 14.05% (173 companies)
Current Ratio
17.34
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
36.29
as of Sept. 30, 2025
Industry median 10.58 (182 companies)
Net Margin
-561.90%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-561.90%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-13.10%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-0.14%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-0.18%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-0.14%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (-0.1%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 2 met
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 4 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.3%
Low 25.2500 · High 27.0000
1W return
2.0%
Low 24.1100 · High 27.0000
1M return
-3.4%
Low 23.8000 · High 36.8000
52W return
Data unavailable.
Low 20.3300 · High 36.8000
Lifetime High ₹35.2200 (Sept. 10, 2026)
Lifetime Low ₹23.5600 (Aug. 19, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish3
5D
25.7
10D
25.9
20D
26.0

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
49.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

25.95
Pivot
First resistance26.65
Second resistance27.70
Third resistance28.40
First support24.90
Second support24.20
Third support23.15
Day RSI48.1
Day MFI80.0
Day MACD—
Day MACD signal—

Beta

1M0.24
3M1.14
1Y1.14
3Y1.14

Price change analysis

↓ -3.4%
Over 1 Month
LowHigh
23.8036.80
—
Over 3 Months
LowHigh
20.3336.80
—
Over 6 Months
LowHigh
20.3336.80
—
Over 1 Year
LowHigh
20.3336.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹-1 Cr
Basic EPS (June 30, 2026)
₹-0.4700

Ranks #161 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter51.44%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 51.36% to 51.44% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

DateClientDealActionQuantityPriceExchange
8 Jan 2025 MANJU GAGGAR Bulk Buy 125,000 57.4100 BSE
5 Apr 2024 DHEERAJ KUMAR LOHIA Bulk Buy 79,371 50.0300 BSE
5 Apr 2024 GOPAL KRISHNA MAHESHWARI Bulk Sell 86,519 50.4800 BSE
3 Mar 2023 KANWARINDERPAL SAHNI Bulk Sell 98 39.7000 BSE
3 Mar 2023 KANWARINDERPAL SAHNI Bulk Buy 62,449 38.3700 BSE
28 Jun 2021 DIPAK KANAYALAL SHAH Bulk Sell 100,000 42.7000 BSE
9 Mar 2021 ANAND VELUMANI Bulk Buy 80,000 41.0000 BSE
19 Feb 2021 DIPAK KANAYALAL SHAH Bulk Sell 85,736 28.8300 BSE
7 Mar 2017 DIPAK KANAYALAL SHAH Bulk Buy 121,769 29.5300 BSE
28 Dec 2015 YUGA STOCKS AND COMMODITIES PRIVATE LIMITED Bulk Buy 73,620 36.5500 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Insider Trading / SAST Medi Caps Ltd-$ - 523144 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (36.3x)

Weaknesses

  • Low Return on Equity (-0.1%)
  • Thin net profit margin (-561.9%)
  • Declining revenue YoY (-40.1%)
  • Declining profit YoY (-48.2%)

Opportunities

  • Trading below book value (PB 0.29)

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Medi Caps Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.